Publication | Closed Access

Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals

Antimicrobial SusceptibilityAntibioticsKlebsiella PneumoniaeSusceptibility ProfileAntibacterial AgentAntimicrobial TherapyMicrobiologyInfection ControlFrom Us HospitalsAntimicrobial ChemotherapyMedicineClinical MicrobiologyAntimicrobial Resistance